Application of Genomics in Complex Disorders: Focus on Pharmacogenomics Informed Theraputics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 1281
Special Issue Editor
Special Issue Information
Dear Colleagues,
The field of genomics has seen unprecedented progresses in the development of novel experimental and analytical tools that are supporting the transition of clinical practice toward precision medicine. Data driven medical approaches are starting to see implementation in several areas including oncology, neurology, and to some extent, psychiatry. The use of omics technologies, integrated by digital monitoring data, electronic health records, and other omics technologies (metabolomics, proteomics, epigenomics) is increasing the accuracy of prediction for specific for complex traits. For instance, the analysis of genome-wide derived polygenic risk score integrated by cognitive data and brain imaging has reached adequate levels of accuracy for clinical implementation in neurodegenerative disorders. This special issue aims to collect novel research data and syntheses of the literature on the progresses of genomic research in complex disorders, focusing on the clinical relevance of risk prediction algorithms and data driven clinical decision making (i.e., pharmacogenomics informed theraputics).
Prof. Dr. Mirko Manchia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
